Eczema is an umbrella term for a group of conditions that result in skin irritation and inflammation. The most common form of ...

Contrary to some commonly held beliefs, current research shows that cutting out certain foods makes little difference in ...

Amgen’s $400 million eczema drug candidate has recorded two more phase 3 victories. The data drops provide more evidence that ...

Half of patients who used delgocitinib cream for chronic hand eczema had a profound response, and a third who stopped ...

Let's uncover the hidden truths behind why your eczema keeps returning and what you can do to get long-term relief.

This NIHR Collection brings together major studies on the prevention and treatment of childhood eczema. It finds that many common interventions are not effective. Studies also explore the support that ...

ABC News medical correspondent Dr. Darien Sutton answers your health questions and shares tips for managing a toothache.

Eli Lilly (NYSE:LLY) on Friday said that its recently approved eczema therapy Ebglyss led to complete skin clearance in 50% ...

Raw Sugar’s new line of shampoo/conditioner directly addresses eczema issues. The post RawSugar’s new shampoo and conditioner ...

After scoring a long-awaited FDA approval last fall, Eli Lilly has launched a consumer-facing campaign to get the word out ...

Learn more Redness, dryness, scaly patches, and itchy rashes — these are just a few of the not-so-fun symptoms of eczema, also known as atopic dermatitis. It's a pretty common condition ...

Organon (OGN) announced results from an analysis of the Phase 3 ADORING 3 open-label, long-term extension study evaluating VTAMA cream, 1% once ...